Laboratorio Teuto
Anápolis, Brazil· Est.
Brazil’s leading full‑stack pharma, Teuto combines legacy manufacturing expertise with modern biosimilar development to supply affordable medicines nationwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Brazil’s leading full‑stack pharma, Teuto combines legacy manufacturing expertise with modern biosimilar development to supply affordable medicines nationwide.
OncologyGeneral MedicineInfectious DiseaseChronic DiseaseNutraceuticals
Technology Platform
Advanced German‑engineered manufacturing automation combined with high‑purity water treatment and end‑to‑end traceability to produce tablets, capsules, and biologics at scale.
Opportunities
Expansion of biosimilar portfolio and entry into other Latin American markets can drive significant revenue growth.
Risk Factors
Regulatory hurdles, price controls, and intense competition could limit market penetration of new products.
Competitive Landscape
Competes with EMS, Eurofarma, and Aché; differentiates through large‑scale integrated manufacturing and a growing biosimilar line.